Phase III Trial Finds Equivalent OS Rates Between APBI Brachytherapy and Whole Breast Irradiation Therapy November 03, 2015Vol.38 No.10
Drugs & Targets FDA Approves Imlygic as First Oncolytic Viral Therapy in the U.S., for Melanoma November 03, 2015Vol.38 No.10
Drugs & Targets FDA Approves Varubi for Chemotherapy-Induced Nausea and Vomiting October 01, 2015Vol.38 No.09
Telotristat Etiprate Demonstrates Clinical Benefit in Phase III Carcinoid Syndrome Study October 01, 2015Vol.38 No.09
Cyramza Increases PFS In Phase II Study of Bladder Cancer Patients Who Failed Platinum Therapy October 01, 2015Vol.38 No.09
Two NEJM Papers Evaluate Imetelstat in Myelofibrosis and Essential Thrombocythemia October 01, 2015Vol.38 No.09
Additional Analyses Show Custirsen Lowered Serum Clusterin Levels in CRPC Patients October 01, 2015Vol.38 No.09
